XAIR Beyond Air, Inc.


$ 1.34 $ -0.04 (-2.92 %)    

Thursday, 20-Nov-2025 12:52:42 EST
QQQ $ 593.45 $ -18.22 (-2.98 %)
DIA $ 460.16 $ -6.52 (-1.4 %)
SPY $ 658.94 $ -13.96 (-2.07 %)
TLT $ 89.21 $ 0.22 (0.25 %)
GLD $ 374.02 $ -1.12 (-0.3 %)
$ na
$ 1.37
$ 1.30 x 900
$ 1.36 x 100
$ 1.33 - $ 1.42
$ 1.29 - $ 13.52
40,193
na
10.81M
$ 0.88
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 d-boral-capital-maintains-buy-on-beyond-air-maintains-11-price-target

D. Boral Capital analyst Jason Kolbert maintains Beyond Air (NASDAQ:XAIR) with a Buy and maintains $11 price target.

 beyond-air-lowers-fy2026-sales-guidance-from-12000m-16000m-to-8000m-10000m-vs-13117m-est

Financial Guidance for Fiscal Year 2026The Company updated its revenue guidance to $8 to $10 million for the fiscal year ending...

 beyond-air-q2-eps-125-misses-085-estimate-sales-1818m-miss-2487m-estimate

Beyond Air (NASDAQ:XAIR) reported quarterly losses of $(1.25) per share which missed the analyst consensus estimate of $(0.85) ...

 beyond-air-signs-32m-financing-agreement-with-streeterville-capital

Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharm...

 beyond-air-exercises-outstanding-common-warrants-for-gross-proceeds-of-325m-through-immediate-exercise-of-144m-warrants-at-221share-issues-720k-new-warrants-at-00625-with-5-year-term

Beyond Air, Inc.

 beyond-air-granted-orphan-designation-status-for-7-nitro-1h-indazole-for-the-treatment-of-malignant-glioma

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1091925

 d-boral-capital-maintains-buy-on-beyond-air-maintains-11-price-target

D. Boral Capital analyst Jason Kolbert maintains Beyond Air (NASDAQ:XAIR) with a Buy and maintains $11 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION